These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38238620)

  • 1. Tenecteplase Plus Butyphthalide for Stroke Within 4.5-6 Hours of Onset (EXIT-BT): a Phase 2 Study.
    Chen HS; Chen MR; Cui Y; Shen XY; Zhang H; Lu J; Zhao LW; Duan YJ; Li J; Wang YM; Min LQ; Zhao LH; Wan LS; Zhang ZH; Nguyen TN
    Transl Stroke Res; 2024 Jan; ():. PubMed ID: 38238620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous Tenecteplase for Acute Ischemic Stroke Within 4.5-24 Hours of Onset (ROSE-TNK): A Phase 2, Randomized, Multicenter Study.
    Wang L; Dai YJ; Cui Y; Zhang H; Jiang CH; Duan YJ; Zhao Y; Feng YF; Geng SM; Zhang ZH; Lu J; Zhang P; Zhao LW; Zhao H; Ma YT; Song CG; Zhang Y; Chen HS
    J Stroke; 2023 Sep; 25(3):371-377. PubMed ID: 37608533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials.
    Ramakrishnan TCR; Kumaravelu S; Narayan SK; Buddha SS; Murali C; Majeed PHA; Meenakshi-Sundaram S; Wadia RS; Sharma V; Basu I; Vijaya P; Salam KA; Barmare S; Vaid Z; Nirmal Raj KK; Wattamwar PR; Asokan K; Dhonge V; Nellikunja S; Namjoshi D; Srinivasa R; Laddhad DS; Deshpande SD; Raghunath B; Kalita J; Kumar M; Misra UK; Pradeep M;
    Am J Cardiovasc Drugs; 2018 Oct; 18(5):387-395. PubMed ID: 29948822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenecteplase versus alteplase for patients with acute ischemic stroke: a meta-analysis of randomized controlled trials.
    Zhang X; Wan TF; Chen J; Liu L
    Aging (Albany NY); 2023 Dec; 15(24):14889-14899. PubMed ID: 38149983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenecteplase for the treatment of acute ischemic stroke in the extended time window: a systematic review and meta-analysis.
    Palaiodimou L; Katsanos AH; Turc G; Romoli M; Theodorou A; Lemmens R; Sacco S; Velonakis G; Vlachopoulos C; Tsivgoulis G
    Ther Adv Neurol Disord; 2024; 17():17562864231221324. PubMed ID: 38193030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke: The EXTEND-IA TNK Part 2 Randomized Clinical Trial.
    Campbell BCV; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Dowling RJ; Yan B; Bush SJ; Thijs V; Scroop R; Simpson M; Brooks M; Asadi H; Wu TY; Shah DG; Wijeratne T; Zhao H; Alemseged F; Ng F; Bailey P; Rice H; de Villiers L; Dewey HM; Choi PMC; Brown H; Redmond K; Leggett D; Fink JN; Collecutt W; Kraemer T; Krause M; Cordato D; Field D; Ma H; O'Brien B; Clissold B; Miteff F; Clissold A; Cloud GC; Bolitho LE; Bonavia L; Bhattacharya A; Wright A; Mamun A; O'Rourke F; Worthington J; Wong AA; Levi CR; Bladin CF; Sharma G; Desmond PM; Parsons MW; Donnan GA; Davis SM;
    JAMA; 2020 Apr; 323(13):1257-1265. PubMed ID: 32078683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial.
    Singh N; Almekhlafi MA; Bala F; Ademola A; Coutts SB; Deschaintre Y; Khosravani H; Buck B; Appireddy R; Moreau F; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar JJ; Ghrooda E; Poppe AY; Williams H; Field TS; Manosalva A; Siddiqui MM; Zafar A; Imoukhoude O; Hunter G; Shamy M; Demchuk AM; Claggett BL; Hill MD; Sajobi TT; Swartz RH; Menon BK
    Stroke; 2023 Nov; 54(11):2766-2775. PubMed ID: 37800372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of intravenous thrombolysis with tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis.
    Wei H; Fu B; Yang C; Huang M
    Neurol Sci; 2023 Sep; 44(9):3005-3015. PubMed ID: 37061572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study.
    Huang X; Cheripelli BK; Lloyd SM; Kalladka D; Moreton FC; Siddiqui A; Ford I; Muir KW
    Lancet Neurol; 2015 Apr; 14(4):368-76. PubMed ID: 25726502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the optimal dose of tenecteplase before endovascular therapy for ischemic stroke (EXTEND-IA TNK Part 2): A multicenter, randomized, controlled study.
    Campbell BC; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Yan B; Thijs V; Desmond PM; Parsons MW; Donnan GA; Davis SM
    Int J Stroke; 2020 Jul; 15(5):567-572. PubMed ID: 31564231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-arterial tenecteplase during thrombectomy for acute stroke (BRETIS-TNK II): rationale and design.
    Zhao ZA; Qiu J; Li W; Nguyen T; Wang S; Shi H; Wei M; Wang F; Li D; Chen HS
    Stroke Vasc Neurol; 2024 Feb; 9(1):59-65. PubMed ID: 37169399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Tenecteplase and Alteplase in Patients With Tandem Lesion Stroke: A Post Hoc Analysis of the EXTEND-IA TNK Trials.
    Yogendrakumar V; Churilov L; Mitchell PJ; Kleinig TJ; Yassi N; Thijs V; Wu T; Shah D; Bailey P; Dewey HM; Choi PMC; Ma A; Wijeratne T; Garcia-Esperon C; Cloud G; Chandra RV; Cordato DJ; Yan B; Sharma G; Desmond PM; Parsons MW; Donnan GA; Davis SM; Campbell BCV;
    Neurology; 2023 May; 100(18):e1900-e1911. PubMed ID: 36878701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-arterial tenecteplase is safe and may improve the first-pass recanalization for acute ischemic stroke with large-artery atherosclerosis: the BRETIS-TNK trial.
    Zhao ZA; Qiu J; Wang L; Zhao YG; Sun XH; Li W; Liu X; Li XL; Liu L; Chen MR; Chen HS
    Front Neurol; 2023; 14():1155269. PubMed ID: 37143999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenecteplase and Alteplase for Thrombolysis of Acute Ischemic Stroke within 4.5 Hours: An Efficacy and Safety Study.
    Dhar N; Kumar M; Tiwari A; Desai I; Madhaw G; Kumar N
    Ann Indian Acad Neurol; 2022; 25(5):897-901. PubMed ID: 36561006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous Thrombolytics in the Treatment of Acute Ischemic Stroke.
    Alhadid K; Oliveira L; Etherton MR
    Curr Treat Options Cardiovasc Med; 2023; 25(1):15-28. PubMed ID: 36618509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial.
    Roaldsen MB; Eltoft A; Wilsgaard T; Christensen H; Engelter ST; Indredavik B; Jatužis D; Karelis G; Kõrv J; Lundström E; Petersson J; Putaala J; Søyland MH; Tveiten A; Bivard A; Johnsen SH; Mazya MV; Werring DJ; Wu TY; De Marchis GM; Robinson TG; Mathiesen EB;
    Lancet Neurol; 2023 Feb; 22(2):117-126. PubMed ID: 36549308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Butylphthalide in Patients With Acute Ischemic Stroke: A Randomized Clinical Trial.
    Wang A; Jia B; Zhang X; Huo X; Chen J; Gui L; Cai Y; Guo Z; Han Y; Peng Z; Jing P; Chen Y; Liu Y; Yang Y; Wang F; Sun Z; Li T; Sun H; Yuan H; Shao H; Gao L; Zhang P; Wang F; Cao X; Shi W; Li C; Yang J; Zhang H; Wang F; Deng J; Liu Y; Deng W; Song C; Chen H; He L; Zhao H; Li X; Yang H; Zhou Z; Wang Y; Miao Z;
    JAMA Neurol; 2023 Aug; 80(8):851-859. PubMed ID: 37358859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study.
    Li S; Pan Y; Wang Z; Liang Z; Chen H; Wang D; Sui Y; Zhao X; Wang Y; Du W; Zheng H; Wang Y
    Stroke Vasc Neurol; 2022 Feb; 7(1):47-53. PubMed ID: 34429364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolysis with Recombinant Human Prourokinase 4.5-6 h After Acute Ischemic Stroke: A Phase IIa, Randomized, and Open-Label Multicenter Clinical Trial.
    Song H; Wang Y; Ma Q; Chen H; Liu B; Yang Y; Zhu J; Zhao S; Jin X; Li Y; Wang Y; Zhu R; Zhao L; Liu J; Feng W; Liu R; Ji X; Wang Y
    CNS Drugs; 2024 Jan; 38(1):67-75. PubMed ID: 38030867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of tenecteplase versus alteplase for acute ischemic stroke: an updated systematic review, pairwise, and network meta-analysis of randomized controlled trials.
    Abuelazm M; Seri AR; Awad AK; Ahmad U; Mahmoud A; Albazee E; Kambalapalli S; Abdelazeem B
    J Thromb Thrombolysis; 2023 Feb; 55(2):322-338. PubMed ID: 36449231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.